The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges
Description
Overall survival (OS) is considered the standard clinical endpoint to support effectiveness claims in new drug applications globally, particularly for lethal conditions such as cancer. However, the source and reliability of OS in the setting of
